1. Home
  2. BGT vs PRQR Comparison

BGT vs PRQR Comparison

Compare BGT & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Floating Rate Income Trust

BGT

BlackRock Floating Rate Income Trust

HOLD

Current Price

$10.70

Market Cap

317.3M

Sector

Finance

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.60

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGT
PRQR
Founded
N/A
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
317.3M
185.4M
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
BGT
PRQR
Price
$10.70
$1.60
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$7.67
AVG Volume (30 Days)
116.7K
285.7K
Earning Date
01-01-0001
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.21
$1.08
52 Week High
$12.76
$3.10

Technical Indicators

Market Signals
Indicator
BGT
PRQR
Relative Strength Index (RSI) 31.28 44.87
Support Level N/A $1.33
Resistance Level $11.44 $2.27
Average True Range (ATR) 0.12 0.11
MACD 0.00 -0.00
Stochastic Oscillator 28.20 19.00

Price Performance

Historical Comparison
BGT
PRQR

About BGT BlackRock Floating Rate Income Trust

Blackrock Floating Rate Income Trust is a diversified closed-end management investment company. Its investment objective is to provide a high level of current income. The company, as a secondary objective, also focuses on preservation of capital to the extent consistent with its primary objective of high current income. The Trust seeks to achieve its investment objectives by investing in worl-wide portfolio of floating rate securities, including investing a substantial amount in U.S. and non-U.S. senior secured floating rate loans (Senior Loans), made to corporate and other business entities.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: